|
|
The newly identified coronavirus, SARS-CoV-2 (previously known as 2019-nCoV), has led to the global COVID-19 outbreak. SARS-CoV-2 shares 79.5% sequence identify with SARS-CoV. The viral genome encodes spike, envelope, membrane, and nucleocapsid proteins.
The nucleocapsid protein is the most abundant protein in coronavirus and is often used as a marker in diagnostic assays. arigo is proud to introduce the newly released recombinant human anti-SARS-CoV-2 nucleocapsid protein antibody (ARG66735) and SARS-CoV-2 recombinant proteins. The antibody and proteins are ideal for understanding the molecular mechanism of viral infection and pathogenesis. Moreover, it is the best solution for validation testing of newly developed diagnostic reagents or therapeutic strategies for COVID-19. | | |
|
Goat anti-Human IgG antibody (FITC),
pre-adsorbed (ARG20568)
Application: FACS, ICC/IF, IHC-Fr, IHC-P, WB
Goat anti-Human IgG antibody (Biotin),
pre-adsorbed (ARG21905)
Application: Depletion, ELISA, FACS, ICC, IHC-P, WB | | |
|
|
SARS-CoV-2 recombinant proteins | | | |
|
|
Antibodies cross-react with SARS-CoV-2 | | | |
|
|
Antibodies against SARS-CoV | | | |
|
|
Antibodies for studying viral infection | | | |
|
